Works matching DE "CYCLOOXYGENASE 2 inhibitors"
Results: 1308
Efficacy and Safety of Celecoxib and a Korean SYSADOA (JOINS) for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1036, doi. 10.3390/jcm14041036
- By:
- Publication type:
- Article
Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review.
- Published in:
- Pharmacy, 2025, v. 13, n. 1, p. 18, doi. 10.3390/pharmacy13010018
- By:
- Publication type:
- Article
Cyclooxygenase-2 Inhibitor Reduces Simvistatin-Induced Bone Morphogenetic Protein-2 and Bone Formation in vivo.
- Published in:
- Journal of Oral Implantology, 2007, v. 33, n. 5, p. 316
- By:
- Publication type:
- Article
Citronellol and Geraniol, Components of Rose Oil, Activate Peroxisome Proliferator-Activated Receptor α and γ and Suppress Cyclooxygenase-2 Expression.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2011, v. 75, n. 5, p. 1010, doi. 10.1271/bbb.110039
- By:
- Publication type:
- Article
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 179, doi. 10.1111/vco.12760
- By:
- Publication type:
- Article
COX-2 and c-kit expression in canine gliomas.
- Published in:
- Veterinary & Comparative Oncology, 2013, v. 11, n. 1, p. 63, doi. 10.1111/j.1476-5829.2011.00302.x
- By:
- Publication type:
- Article
Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2011, v. 9, n. 3, p. 161, doi. 10.1111/j.1476-5829.2010.00242.x
- By:
- Publication type:
- Article
Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002–2007).
- Published in:
- Veterinary & Comparative Oncology, 2009, v. 7, n. 4, p. 213, doi. 10.1111/j.1476-5829.2009.00194.x
- By:
- Publication type:
- Article
The effect of renal administration of a selective cyclooxygenase-2 inhibitor or stable prostaglandin I analog on the progression of sclerotic glomerulonephritis in rats.
- Published in:
- Clinical & Experimental Nephrology, 2012, v. 16, n. 2, p. 221, doi. 10.1007/s10157-011-0558-2
- By:
- Publication type:
- Article
Niflumic Acid Affects Store-Operated Ca-Permeable (SOC) and Ca-Dependent K and Cl Ion Channels and Induces Apoptosis in K562 Cells.
- Published in:
- Journal of Membrane Biology, 2014, v. 247, n. 7, p. 627, doi. 10.1007/s00232-014-9680-x
- By:
- Publication type:
- Article
Prognostic significance of cyclooxygenase-2 expression in pediatric Hodgkin and non-Hodgkin lymphomas with or without Epstein–Barr virus latent infection.
- Published in:
- Comparative Clinical Pathology, 2008, v. 17, n. 2, p. 125, doi. 10.1007/s00580-007-0710-2
- By:
- Publication type:
- Article
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications.
- Published in:
- International Orthopaedics, 2024, v. 48, n. 3, p. 699, doi. 10.1007/s00264-023-05993-6
- By:
- Publication type:
- Article
Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
- Published in:
- International Orthopaedics, 2013, v. 37, n. 4, p. 583, doi. 10.1007/s00264-013-1781-0
- By:
- Publication type:
- Article
Perioperative use of an anti-inflammatory drug on tooth sensitivity caused by in-office bleaching: a randomized, triple-blind clinical trial.
- Published in:
- Clinical Oral Investigations, 2013, v. 17, n. 9, p. 2091, doi. 10.1007/s00784-013-0918-2
- By:
- Publication type:
- Article
Characterization and Molecular Docking Study of New 4-Acetamidoalkyl Pyrazoles As B-Raf /Cox-2 Inhibitors.
- Published in:
- Journal of Structural Chemistry, 2018, v. 59, n. 2, p. 335, doi. 10.1134/S0022476618020117
- By:
- Publication type:
- Article
Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer.
- Published in:
- Discover Nano, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s11671-024-04070-0
- By:
- Publication type:
- Article
Hard times at the FDA.
- Published in:
- Nature Immunology, 2005, v. 6, n. 2, p. 115, doi. 10.1038/ni0205-115
- Publication type:
- Article
Crystallization of Celecoxib in Microemulsion Media.
- Published in:
- Journal of Dispersion Science & Technology, 2007, v. 28, n. 8, p. 1228, doi. 10.1080/01932690701528035
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment.
- Published in:
- Neuropsychopharmacology, 2005, v. 30, n. 6, p. 1204, doi. 10.1038/sj.npp.1300690
- By:
- Publication type:
- Article
Response.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
RE: Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 107, n. 1, p. 1, doi. 10.1093/jnci/dju345
- By:
- Publication type:
- Article
Tolfenamic Acid and Pancreatic Cancer Growth, Angiogenesis, and Sp Protein Degradation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 12, p. 855, doi. 10.1093/jnci/djj232
- By:
- Publication type:
- Article
Celecoxib Shown Effective in Preventing Colon Polyps.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 10, p. 665, doi. 10.1093/jnci/djj220
- By:
- Publication type:
- Article
Clinical Trial Transparency: Registries, Databases Raise Questions, Stir Debate.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 22, p. 1640, doi. 10.1093/jnci/dji421
- By:
- Publication type:
- Article
Rescuing COX-2 Inhibitors From the Waste Bin.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Researchers Plan To Continue To Study COX-2 Inhibitors in Cancer Treatment and Prevention.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 8, p. 552, doi. 10.1093/jnci/97.8.552
- By:
- Publication type:
- Article
Prevention Study Halted Amid Concerns About Celebrex.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 2, p. 91
- Publication type:
- Article
Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 23, p. 1769, doi. 10.1093/jnci/djh322
- By:
- Publication type:
- Article
Death Receptor Regulation and Celecoxib-Induced Apoptosis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 23, p. 1727
- Publication type:
- Article
Design, Synthesis, Drug-Likeness, anti-Inflammatory, Antimicrobial Activity, and Molecular Docking Studies of Pyrimidine Analogs.
- Published in:
- Polycyclic Aromatic Compounds, 2024, v. 44, n. 10, p. 6957, doi. 10.1080/10406638.2024.2331519
- By:
- Publication type:
- Article
Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2022.2162511
- By:
- Publication type:
- Article
Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 1737, doi. 10.1080/14756366.2022.2086868
- By:
- Publication type:
- Article
Design and synthesis of novel quinazolinones conjugated ibuprofen, indole acetamide, or thioacetohydrazide as selective COX-2 inhibitors: anti-inflammatory, analgesic and anticancer activities.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 1810, doi. 10.1080/14756366.2021.1956912
- By:
- Publication type:
- Article
Structure-based design, synthesis, molecular docking study and biological evaluation of 1,2,4-triazine derivatives acting as COX/15-LOX inhibitors with anti-oxidant activities.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2016, v. 31, n. 6, p. 1602, doi. 10.3109/14756366.2016.1158713
- By:
- Publication type:
- Article
Design, synthesis and structure-activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, v. 29, n. 6, p. 846, doi. 10.3109/14756366.2013.864650
- By:
- Publication type:
- Article
QSAR of 2-(4-methylsulphonylphenyl)pyrimidine derivatives as cyclooxygenase-2 inhibitors: simple structural fragments as potential modulators of activity.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2012, v. 27, n. 2, p. 249, doi. 10.3109/14756366.2011.587414
- By:
- Publication type:
- Article
Synthesis and biological evaluation of 2,5-disubstituted 1,3,4-oxadiazole derivatives with both COX and LOX inhibitory activity.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2011, v. 26, n. 6, p. 767, doi. 10.3109/14756366.2010.550890
- By:
- Publication type:
- Article
Quantitative structure–activity relationship analysis of 2,3-diaryl indoles as selective cyclooxygenase-2 inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2005, v. 20, n. 5, p. 455, doi. 10.1080/14756360500277251
- By:
- Publication type:
- Article
Impact of Medicaid Prior Authorization Requirement for COX-2 Inhibitor Drugs in Nebraska.
- Published in:
- Health Services Research, 2008, v. 43, n. 1p2, p. 435, doi. 10.1111/j.1475-6773.2007.00766.x
- By:
- Publication type:
- Article
Attenuation of Pro-inflammatory Neuropeptide Levels Produced by a Cyclooxygenase-2 Inhibitor in an Animal Model of Chronic Temporomandibular Joint Inflammation.
- Published in:
- Journal of Orofacial Pain, 2002, v. 16, n. 4, p. 312
- By:
- Publication type:
- Article
British Prostate Group BAUS Section of Oncology British Uro-Oncology Group.
- Published in:
- 2006
- Publication type:
- Abstract
Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2006, v. 23, n. 1, p. 8, doi. 10.1159/000096588
- By:
- Publication type:
- Article
Role of prostaglandins on mechanical scratching-induced cutaneous barrier disruption in mice.
- Published in:
- Experimental Dermatology, 2007, v. 16, n. 6, p. 507, doi. 10.1111/j.1600-0625.2007.00548.x
- By:
- Publication type:
- Article
Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib.
- Published in:
- Contact Dermatitis (01051873), 2012, v. 66, n. 2, p. 107, doi. 10.1111/j.1600-0536.2011.01982.x
- By:
- Publication type:
- Article
Cutaneous reaction to oral celecoxib with positive patch test.
- Published in:
- 2004
- By:
- Publication type:
- Case Study
Lumbrokinase Extracted from Earthworms Synergizes with Bevacizumab and Chemotherapeutics in Treating Non-Small Cell Lung Cancer by Targeted Inactivation of BPTF/VEGF and NF-κB/COX-2 Signaling.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 7, p. 741, doi. 10.3390/biom14070741
- By:
- Publication type:
- Article
Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 7, p. 1049, doi. 10.3390/biom11071049
- By:
- Publication type:
- Article
Exploring a potential role for selective COX‐2 inhibitors for the prevention of hemophilic arthropathy.
- Published in:
- Haemophilia, 2022, v. 28, n. 6, p. e254, doi. 10.1111/hae.14659
- By:
- Publication type:
- Article
Total joint arthroplasty in the patients with haemophilia: General or neuraxial anaesthesia?
- Published in:
- Haemophilia, 2022, v. 28, n. 4, p. e95, doi. 10.1111/hae.14509
- By:
- Publication type:
- Article